Company / Revenue
Korro Bio, Inc. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$2.3M
FY2025
5-year range
$0 / $37.0M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue returned to growth in FY2025 after 2 years of decline, reaching $2M.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -39.9%.
Declined from $14M to $2M over the past 3 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -45.6%
- 5-Year CAGR
- -39.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -39.9%, indicating a declining trend.
- Peak revenue was recorded in FY2021.
- Lowest revenue in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.3M | - |
| FY2024 | $0 | -100.0% |
| FY2022 | $14.1M | -62.0% |
| FY2021 | $37.0M | +27.8% |
| FY2020 | $28.9M | +19.4% |
| FY2019 | $24.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026